Related Experiment Video
Updated: May 24, 2026
12:44
The In ovo CAM-assay as a Xenograft Model for Sarcoma
Published on: July 17, 2013
Primary intracranial extraskeletal myxoid chondrosarcoma.
Renaud Dulou1, Cyrus Chargari, Arnaud Dagain
1Department of Neurosurgery, Val-de-Grâce Hospital, Paris, France. renaud.dulou@gmail.com
Neurologia I Neurochirurgia Polska
|March 20, 2012
Summary
Extraskeletal myxoid chondrosarcomas (EMC) are rare tumors. This case highlights the challenges in diagnosing and managing intracranial EMC, emphasizing complete surgical resection for better patient outcomes.
Area of Science:
- Oncology
- Neuropathology
Background:
- Extraskeletal myxoid chondrosarcomas (EMC) are rare soft tissue tumors, with intracranial occurrences being exceptionally uncommon.
- Diagnosis and management of intracranial EMC are challenging due to their rarity and typical presentation mimicking other brain lesions.
Observation:
- A case of intracranial EMC in a 70-year-old woman presenting as a right frontal mass, initially misdiagnosed as breast adenocarcinoma metastasis.
- The rarity of intracranial EMC (fewer than 10 reported cases) complicates early identification and treatment strategies.
Findings:
- Complete surgical resection is recommended as the primary treatment modality for intracranial EMC when feasible.
- EMC demonstrates relative resistance to conventional radiotherapy and chemotherapy, leading to a high risk of relapse post-surgery.
Implications:
- Multimodal treatment approaches, including conformal radiotherapy and novel molecular therapies, may offer future therapeutic avenues.
- Increased awareness and knowledge of these rare intracranial tumors are crucial for improving patient prognosis and outcomes.
